These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19734741)

  • 1. Sulphasalazine induced three-week syndrome.
    Suresh R; Gupta S; Sathananthan R
    J Clin Rheumatol; 2009 Sep; 15(6):311-2. PubMed ID: 19734741
    [No Abstract]   [Full Text] [Related]  

  • 2. [DRESS syndrome as a result of sulfasalazine use].
    van der Mark SC; Segers D; Bakker RC; van Wijngaarden P
    Ned Tijdschr Geneeskd; 2010; 154(18):A2161. PubMed ID: 23134745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine-induced DRESS.
    Teo L; Tan E
    Singapore Med J; 2006 Mar; 47(3):237-9. PubMed ID: 16518561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sulfasalazine-induced DRESS syndrome associated with Epstein Barr virus reactivation].
    Zaïem A; Aouinti I; Lakhoua G; Sahnoun R; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2013; 68(5):321-3. PubMed ID: 24225043
    [No Abstract]   [Full Text] [Related]  

  • 6. Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985.
    Drugs; 1986; 32 Suppl 1():1-80. PubMed ID: 2877848
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin manifestations of a case of phenylbutazone-induced serum sickness-like reactions.
    Sánchez G; Vila L; Pajarón M; Diéguez I
    J Investig Allergol Clin Immunol; 2000; 10(3):170-2. PubMed ID: 10923593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test.
    Jaeger C; Jappe U
    Contact Dermatitis; 2005 Jan; 52(1):47-8. PubMed ID: 15701133
    [No Abstract]   [Full Text] [Related]  

  • 10. Rash and fever after sulfasalazine use.
    Raithatha N; Mehrtens S; Mouyis M; Manson J
    BMJ; 2014 Oct; 349():g5655. PubMed ID: 25296685
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.
    Rosenbaum J; Alex G; Roberts H; Orchard D
    J Paediatr Child Health; 2010 Apr; 46(4):193-6. PubMed ID: 20546480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challenge.
    van Riel PL; van de Putte LB
    Neth J Med; 1990 Jun; 36(5-6):221-2. PubMed ID: 1975649
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE; Amos RS
    Drugs; 1986; 32 Suppl 1():73-6. PubMed ID: 2877858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis.
    Augusto JF; Sayegh J; Simon A; Croue A; Chennebault JM; Cousin M; Subra JF
    Nephrol Dial Transplant; 2009 Sep; 24(9):2940-2. PubMed ID: 19509026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphadenopathy due to sulfasalazine in rheumatoid polyarthritis].
    Lafeuillade A; Bolla G; Horschowski N; Fossat C; David M; Salvator V; Schiano A
    Presse Med; 1989 Oct; 18(34):1709. PubMed ID: 2577027
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug induced intracranial hypertension associated with sulphasalazine treatment.
    Sevgi E; Yalcin G; Kansu T; Varli K
    Headache; 2008 Feb; 48(2):296-8. PubMed ID: 18070060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.
    Amos RS; Bax DE; Greaves MS
    Drugs; 1986; 32 Suppl 1():58. PubMed ID: 2877855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.